The video takes a detailed look at the new 2026 Mercedes CLA Shooting Brake and its blend of sleek styling with extra ...

AbbVie (ABBV) presented detailed Phase 1 multiple ascending dose data for ABBV-295, its investigational long-acting amylin analog for obesity, with least-squares mean body weight reductions ranging ...

Athletes will not be banned from using weight-loss drugs, but the substances will remain on a monitoring list.

Sarah is an experienced writer and editor enthusiastic about helping readers live their healthiest and happiest lives. Before joining Forbes Health, Sarah worked as a writer for various digital ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

While conducting the first official White House press briefing since July 23, when he led it, and the first since former press secretary Karoline Leavitt's departure last month, Vice President JD ...

You don’t have to give up carbs to lose body fat. These dietitian-approved picks can help you stay full and satisfied while working toward your goals. Carbohydrates often get a bad reputation when it ...

An updated systematic review evaluating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and coagonists among adults with overweight or obesity without diabetes found ...

A team of researchers led by scientists at the University of California, Berkeley, has identified a decades-old oral compound that produced substantial weight loss in obese mice. Rather than ...

GLP-1 medications already do double duty as diabetes and obesity treatment. There may be much more to come. From heart health to cancer protection, research keeps uncovering potential benefits of the ...

As GLP-1 medications become more popular, many people are reporting temporary hair loss, a side effect previously blamed on the physical stress of rapid weight loss. However, a new study suggests that ...

More than a dozen experimental obesity drugs are working their way through clinical trials, and the last year has reshuffled the leaderboard: some candidates have advanced into pivotal phase 3 studies ...